Literature DB >> 8809997

The significance of reactions to purified fractions of Dermatophagoides pteronyssinus and Dermatophagoides farinae in canine atopic dermatitis.

C Noli1, W E Bernadina, T Willemse.   

Abstract

The significance of reactions to crude extracts and purified fractions of the house dust mites Dermatophagoides pteronyssinus (Der p I and Der p II) and Dermatophagoides farinae (Der f I and Der f II) was evaluated in dogs with clinical manifestations of atopic dermatitis (AD). In 13 healthy control dogs and eight dogs with AD, immediate skin test reactivity was determined to serial dilutions of Der p I, Der p II, Der f I and Der f II. In addition, allergen-specific IgGd antibodies were determined by means of an enzyme-linked immunosorbent assay (ELISA) and Western blots. The results suggest that, in contrast to what occurs in humans and despite immediate skin test reactivity in some dogs, Der p I, Der p II, Der f I and Der f II are unlikely to be major allergens in dogs with AD. However, only serum of atopic dogs consistently binds a 90 kDa polypeptide of D. farinae, as shown by Western blot analysis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8809997     DOI: 10.1016/0165-2427(96)05550-x

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  3 in total

1.  An international seroprevalence survey of the IgE sensitisation to the Dermatophagoides farinae house dust mite and two of its major allergens (Der f 2, Zen 1) in atopic dogs.

Authors:  Claude Favrot; Thierry Olivry; Toshiro Iwasaki
Journal:  Vet Dermatol       Date:  2021-08-19       Impact factor: 1.867

2.  A retrospective study of hyposensitization in canine atopy based on a polyclonal ELISA test.

Authors:  B K Saevik; S I Thoresen; F Kristensen
Journal:  Vet Res Commun       Date:  2002-12       Impact factor: 2.459

3.  Allergens in veterinary medicine.

Authors:  R S Mueller; J Janda; E Jensen-Jarolim; C Rhyner; E Marti
Journal:  Allergy       Date:  2015-09-11       Impact factor: 13.146

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.